Hypoxia-inducible factor-1 in human breast and prostate cancer

Endocrine-Related Cancer

Volumn 13, Issue 3, 2006, Pages 739-749

  Kimbro, K S ^a   Simons, J W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHOXYESTRADIOL; APURINIC ACID; CYCLOOXYGENASE 2 INHIBITOR; ESTROGEN; HETERODIMER; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN P300; REDOX EFFECTOR FACTOR 1; TRANSCRIPTION FACTOR; TYROSINE KINASE RECEPTOR;

ANGIOGENESIS; BREAST CANCER; EVOLUTIONARY ADAPTATION; GENE CONTROL; HUMAN; HYPOXIA; METASTASIS; MOLECULAR CLONING; NONHUMAN; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; UBIQUITINATION; UPREGULATION;

ANTINEOPLASTIC AGENTS; ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR; BREAST NEOPLASMS; DRUG DESIGN; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; PROSTATIC NEOPLASMS; TRANSCRIPTION, GENETIC;

EID: 33751074452     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.00728     Document Type: Review

References (95)

1. Acs G, Xu X, Chu C, Acs P & Verma A 2004 Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer 100 2376-2386.
2. Airley R, Loncaster J, Davidson S, Bromley M, Roberts S, Patterson A, Hunter R, Stratford I & West C 2001 Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clinical Cancer Research 7 928-934.
3. Alvarez-Tejado M, Naranjo-Suarez S, Jimenez C, Carrera AC, Landazuri MO & del Peso L 2001 Hypoxia induces the activation of the phosphatidylinositol 3-kinase/Akt cell survival pathway in PC12 cells: protective role in apoptosis. Journal of Biological Chemistry 276 22368-22374.
4. Anastasiadis AG, Ghafar MA, Salomon L, Vacherot F, Benedit P, Chen MW, Shabsigh A, Burchardt M, Chopin DK, Shabsigh R et al. 2002 Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha). Journal of Cancer Research and Clinical Oncology 128 358-362.
5. Arany Z, Huang LE, Eckner R, Bhattacharya S, Jiang C, Goldberg MA, Bunn HF & Livingston DM 1996 An essential role for p300/CBP in the cellular response to hypoxia. PNAS 93 12969-12973.
6. Beppu K, Nakamura K, Linehan WM, Rapisarda A & Thiele CJ 2005 Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells. Cancer Research 65 4775-4781.
7. Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S & Naylor S 2003 Hypoxia-mediated tumour targeting. Gene Therapy 10 540-549.
8. Blum R, Jacob-Hirsch J, Amariglio N, Rechavi G & Kloog Y 2005 Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Research 65 999-1006.
9. Boddy JL, Fox SB, Han C, Campo L, Turley H, Kanga S, Malone PR & Harris AL 2005 The androgen receptor is significantly associated with vascular endothelial growth factor and hypoxia sensing via hypoxia-inducible factors HIF-1a, HIF-2a, and the prolyl hydroxylases in human prostate cancer. Clinical Cancer Research 11 7658-7663.
10. Bos R, van Der Hoeven JJ, van Der Wall E, van der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA et al. 2002 Biologic correlates of (18)fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. Journal of Clinical Oncology 20 379-387.
11. Bos R, van der Groep P, Greijer AE, Shvarts A, Meijer S, Pinedo HM, Semenza GL, van Diest PJ & van der Wall E 2003 Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma. Cancer 97 1573-1581.
12. Bos R, van Diest PJ, van der Groep P, Shvarts A, Greijer AE & van der Wall E 2004 Expression of hypoxia-inducible factor-1alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Research 6 R450-R459.
13. Bos R, van Diest PJ, de Jong JS, van der Groep P, van der Valk P & van der Wall E 2005 Hypoxia-inducible factor-1alpha is associated with angiogenesis, and expression of bFGF, PDGF-BB, and EGFR in invasive breast cancer. Histopathology 46 31-36.
14. Carroll VA & Ashcroft M 2005 Targeting the molecular basis for tumour hypoxia. Expert Reviews in Molecular Medicine 7 1-16.
15. Chau NM, Rogers P, Aherne W, Carroll V, Collins I, McDonald E, Workman P & Ashcroft M 2005 Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Research 65 4918-4928.
16. Chun YS, Lee KH, Choi E, Bae SY, Yeo EJ, Huang LE, Kim MS & Park JW 2003 Phorbol ester stimulates the nonhypoxic induction of a novel hypoxia-inducible factor 1alpha isoform: implications for tumor promotion. Cancer Research 63 8700-8707.
17. Dachs GU, Patterson AV, Firth JD, Ratcliffe PJ, Townsend KM, Stratford IJ & Harris AL 1997 Targeting gene expression to hypoxic tumor cells. Nature Medicine 3 515-520.
18. Dales JP, Garcia S, Meunier-Carpentier S, Andrac-Meyer L, Haddad O, Lavaut MN, Allasia C, Bonnier P & Charpin C 2005 Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients. International Journal of Cancer 116 734-739.
19. Delmas C, End D, Rochaix P, Favre G, Toulas C & Cohen-Jonathan E 2003 The farnesyltransferase inhibitor R115777 reduces hypoxia and matrix metalloproteinase 2 expression in human glioma xenograft. Clinical Cancer Research 9 6062-6068.
20. Du Z, Fujiyama C, Chen Y & Masaki Z 2003 Expression of hypoxia-inducible factor 1alpha in human normal, benign, and malignant prostate tissue. Chinese Medical Journal 116 1936-1939.
21. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J & Cheresh DA 1999 Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular Cell 4 915-924.
22. Ellis LM, Staley CA, Liu W, Fleming RY, Parikh NU, Bucana CD & Gallick GE 1998 Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src. Journal of Biological Chemistry 273 1052-1057.
23. Erler JT, Cawthorne CJ, Williams KJ, Koritzinsky M, Wouters BG, Wilson C, Miller C, Demonacos C, Stratford IJ & Dive C 2004 Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance. Molecular and Cellular Biology 24 2875-2889.
24. Fleming RY, Ellis LM, Parikh NU, Liu W, Staley CA & Gallick GE 1997 Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by activity of src kinase. Surgery 122 501-507.
25. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD & Semenza GL 1996 Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Molecular and Cellular Biology 16 4604-4613.
26. Fu XS, Choi E, Bubley GJ & Balk SP 2005 Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. Prostate 63 215-221.
27. Gao N, Jiang BH, Leonard SS, Corum L, Zhang Z, Roberts JR, Antonini J, Zheng JZ, Flynn DC, Castranova V et al. 2002 p38 Signaling-mediated hypoxia-inducible factor 1alpha and vascular endothelial growth factor induction by Cr(VI) in DU145 human prostate carcinoma cells. Journal of Biological Chemistry 277 45041-45048.
28. Gleadle JM & Ratcliffe PJ 1997 Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89 503-509.
29. Gomez-Manzano C, Fueyo J, Jiang H, Glass TL, Lee HY, Hu M, Liu JL, Jasti SL, Liu TJ, Conrad CA et al. 2003 Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Annals of Neurology 53 109-117.
30. Gray MJ, Zhang J, Ellis LM, Semenza GL, Evans DB, Watowich SS & Gallick GE 2005 HIF-lalpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene 24 3110-3120.
31. Gruber G, Greiner RH, Hlushchuk R, Aebersold DM, Altermatt HJ, Berclaz G & Djonov V 2004 Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter? Breast Cancer Research 6 R191-R198.
32. Han JY, Oh SH, Morgillo F, Myers JN, Kim E, Hong WK & Lee HY 2005 Hypoxia-inducible factor 1alpha and antiangiogenic activity of farnesyltransferase inhibitor SCH66336 in human aerodigestive tract cancer. Journal of the National Cancer Institute 97 1272-1286.
33. Hossain CF, Kim YP, Baerson SR, Zhang L, Bruick RK, Mohammed KA, Agarwal AK, Nagle DG & Zhou YD 2005 Saururus cernuus lignans-Potent small molecule inhibitors of hypoxia-inducible factor-1. Biochemical and Biophysical Research Communications 333 1026-1033.
34. Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ & Abraham RT 2002 Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Molecular and Cellular Biology 22 7004-7014.
35. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW & Greenberg NM 2001 Angiogenesis and prostate cancer: identification of a molecular progression switch. Cancer Research 61 2736-2743.
36. Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, Kriegsheim A, Hebestreit HF, Mukherji M, Schofield CJ et al. 2001 Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 468-472.
37. Jiang BH, Rue E, Wang GL, Roe R & Semenza GL 1996 Dimerization DNA, binding, and transactivation properties of hypoxia-inducible factor 1. Journal of Biological Chemistry 271 17771-17778.
38. Jiang BH, Agani F, Passaniti A & Semenza GL 1997 V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Research 57 5328-5335.
39. Jiang BH, Jiang G, Zheng JZ, Lu Z, Hunter T & Vogt PK 2001 Phosphatidylinositol 3-kinase signaling controls levels of hypoxia-inducible factor 1. Cell Growth and Differentiation 12 363-369.
40. Jiang YA, Fan LF, Jiang CQ, Zhang YY, Luo HS, Tang ZJ, Xia D & Wang M 2003 Expression and significance of PTEN, hypoxia-inducible factor-1 alpha in colorectal adenoma and adenocarcinonia. World Journal of Gastroenterology 9 491-494.
41. Jones MK, Szabo IL, Kawanaka H, Husain SS & Tarnawski AS 2002 von Hippel Lindau tumor suppressor and HIF-1alpha: new targets of NSAIDs inhibition of hypoxia-induced angiogenesis. FASEB Journal 16 264-266.
42. Jung JE, Lee HG, Cho IH, Chung DH, Yoon SH, Yang YM, Lee JW, Choi S, Park JW, Ye SK et al. 2005 STAT3 is a potential modulator of HIF-1-mediated VEGF expression in human renal carcinoma cells. FASEB Journal.
43. Kaelin WG, Jr 2005 ROS: really involved in oxygen sensing. Cell Metabolism 1 357-358.
44. Kazi AA, Jones JM & Koos RD 2005 Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Journal of Molecular Endocrinology 19 2006-2019.
45. Kondo K & Kaelin WG, Jr 2001 The von Hippel-Lindau tumor suppressor gene. Experimental Cell Research 264 117-125.
46. Kurebayashi J, Otsuki T, Moriya T & Sonoo H 2001 Hypoxia reduces hormone responsiveness of human breast cancer cells. Japanese Journal of Cancer Research 92 1093-1101.
47. Laughner E, Taghavi P, Chiles K, Mahon PC & Semenza GL 2001 HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression. Molecular and Cellular Biology 21 3995-4004.
48. Lim JH, Lee ES, You HJ, Lee JW, Park JW & Chun YS 2004 Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 23 9427-9431.
49. Luwor RB, Lu Y, Li X, Mendelsohn J & Fan Z 2005 The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression. Oncogene 24 4433-4441.
50. Mabjeesh NJ, Escuin D, La Vallee TM, Pribluda VS, Swartz GM, Johnson MS, Willard MT, Zhong H, Simons JW & Giannakakou P 2003a 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 3 363-375.
51. Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H & Simons JW 2003b Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3′-kinase/protein kinase B in prostate cancer cells. Clinical Cancer Research 9 2416-2425.
52. Macpherson GR & Figg WD 2004 Small molecule-mediated anti-cancer therapy via hypoxia-inducible factor-1 blockade. Cancer Biology and Therapy 3 503-504.
53. Majumder PK, Febbo PG, Bikoff R, Berger R, Xue Q, McMahon LM, Manola J, Brugarolas J, McDonnell TJ, Golub TR et al. 2004 mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nature Medicine 10 594-601.
54. Milas L 2001 Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse. Seminars in Radiation Oncology 11 290-299.
55. Mukhopadhyay D, Tsiokas L, Zhou XM, Foster D, Brugge JS & Sukhatme VP 1995 Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375 577-581.
56. Muzandu K, Shaban Z, Ishizuka M, Kazusaka A & Fujita S 2005 Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells. Free Radical Research 39 389-398.
57. Namiki A, Brogi E, Kearney M, Kim EA, Wu T, Couffinhal T, Varticovski L & Isner JM 1995 Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. Journal of Biological Chemistry 270 31189-31195.
58. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D et al. 2002 Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 21 2000-2008.
59. Palayoor ST, Tofilon PJ & Coleman CN 2003 Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Clinical Cancer Research 9 3150-3157.
60. Petit AM, Rak J, Hung MC, Rockwell P, Goldstein N, Fendly B & Kerbel RS 1997 Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors. American Journal of Pathology 151 1523-1530.
61. Price BD & Calderwood SK 1992 Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Research 52 3814-3817.
62. Pugh CW & Ratcliffe PJ 2003 The von Hippel-Lindau tumor suppressor, hypoxia-inducible factor-1 (HIF-1) degradation, and cancer pathogenesis. Seminars in Cancer Biology 13 83-89.
63. Rak J, Filmus J, Finkenzeller G, Grugel S, Marme D & Kerbel RS 1995 Oncogenes as inducers of tumor angiogenesis. Cancer Metastasis Reviews 14 263-277.
64. Ricker JL, Chen Z, Yang XP, Pribluda VS, Swartz GM & Van Waes C 2004 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma. Clinical Cancer Research 10 8665-8673.
65. Saramaki OR, Savinainen KJ, Nupponen NN, Bratt O & Visakorpi T 2001 Amplification of hypoxia-inducible factor 1alpha gene in prostate cancer. Cancer Genetics and Cytogenetics 128 31-34.
66. Schuringa JJ, Schepers H, Vellenga E & Kruijer W 2001 Ser727-dependent transcriptional activation by association of p300 with STAT3 upon IL-6 stimulation. FEBS Letters 495 71-76.
67. Semenza GL 2001 HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107 1-3.
68. Semenza GL 2002 HIF-1 and tumor progression: pathophysiology and therapeutics. Trends in Molecular Medicine 8 S62-S67.
69. Semenza GL 2003 Targeting HIF-1 for cancer therapy. Nature Reviews Cancer 3 721-732.
70. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P & Giallongo A 1996 Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. Journal of Biological Chemistry 271 32529-32537.
71. Sheflin LG, Zou AP & Spaulding SW 2004 Androgens regulate the binding of endogenous HuR to the AU-rich 3′UTRs of HIF-1alpha and EGF mRNA. Biochemical and Biophysical Research Communications 322 644-651.
72. Sivridis E, Giatromanolaki A, Gatter KC, Harris AL & Koukourakis MI 2002 Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma. Cancer 95 1055-1063.
73. Staley CA, Parikh NU & Gallick GE 1997 Decreased tumorigenicity of a human colon adenocarcinoma cell line by an antisense expression vector specific for c-Src. Cell Growth and Differentiation 8 269-274.
74. Tacchini L, Fusar-Poli D & Bernelli-Zazzera A 2002 Activation of transcription factors by drugs inducing oxidative stress in rat liver. Biochemical Pharmacology 63 139-148.
75. Tan C, de Noronha RG, Roecker AJ, Pyrzynska B, Khwaja F, Zhang Z, Zhang H, Teng Q, Nicholson AC, Giannakakou P et al. 2005 Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Research 65 605-612.
76. Tarnawski AS & Jones MK 2003 Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications. Journal of Molecular Medicine 81 627-636.
77. Vaupel P 2004 The role of hypoxia-induced factors in tumor progression. Oncologist 9 (Suppl 5) 10-17.
78. Vaupel P, Kelleher DK & Hockel M 2001 Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Seminars in Oncology 28 29-35.
79. Vleugel MM, Bos R, Buerger H, van der Groep P, Saramaki OR, Visakorpi T, van der Wall E & van Diest PJ 2004 No amplifications of hypoxia-inducible factor-1alpha gene in invasive breast cancer: a tissue microarray study. Cellular Oncology 26 347-351.
80. Vleugel MM, Greijer AE, Shvarts A, van der Groep P, van Berkel M, Aarbodem Y, van Tinteren H, Harris AL, van Diest PJ & van der Wall E 2005a Differential prognostic impact of hypoxia induced and diffuse HIF-1 alpha expression in invasive breast cancer. Journal of Clinical Pathology 58 172-177.
81. Vleugel MM, Greijer AE, van der Wall E & van Diest PJ 2005b Mutation analysis of the HIF-1alpha oxygen-dependent degradation domain in invasive breast cancer. Cancer Genetics and Cytogenetics 163 168-172.
82. Volm M & Koomagi R 2000 Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer. Anticancer Research 20 1527-1533.
83. Wang M, Kirk JS, Venkataraman S, Domann FE, Zhang HJ, Schafer FQ, Flanagan SW, Weydert CJ, Spitz DR, Buettner GR et al. 2005 Manganese superoxide dismutase suppresses hypoxic induction of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor. Oncogene .
84. Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL & Xie K 2003 Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis. Oncogene 22 319-329.
85. Welsh S, Williams R, Kirkpatrick L, Paine-Murrieta G & Powis G 2004 Antitumor activity and pharmacodynamic properties of PX-478, an inhibitor of hypoxia-inducible factor-1alpha. Molecular Cancer Therapeutics 3 233-244.
86. Wiedmann MW & Caca K 2005 Molecularly targeted therapy for gastrointestinal cancer. Current Cancer Drug Targets 5 171-193.
87. Yen L, Benlimame N, Nie ZR, Xiao D, Wang T, Al Moustafa AE, Esumi H, Milanini J, Hynes NE, Pages G et al. 2002 Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Molecular Biology of the Cell 13 4029-4044.
88. Zagzag D, Krishnamachary B, Yee H, Okuyama H, Chiriboga L, Ali MA, Melamed J & Semenza GL 2005 Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Cancer Research 65 6178-6188.
89. Zhang W, Tsuchiya T & Yasukochi Y 1999 Transitional change in interaction between HIF-1 and HNF-4 in response to hypoxia. Journal of Human Genetics 44 293-299.
90. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL & Simons JW 1999 Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Research 59 5830-5835.
91. Zhong H, Chiles K, Feldser D, Laughner E, Hanrahan C, Georgescu MM, Simons IW & Semenza GL 2000 Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Research 60 1541-1545.
92. Zhong H, Semenza GL, Simons JW & De Marzo AM 2004a Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. Cancer Detection and Prevention 28 88-93.
93. Zhong H, Willard M & Simons I 2004b NS398 reduces hypoxia-inducible factor (HIF)-1alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms. International Journal of Cancer 112 585-595.
94. Zhong XS, Zheng JZ, Reed E & Jiang BH 2004c SU5416 inhibited VEGF and HIF-1alpha expression through the PI3K/AKT/p70S6K1 signaling pathway. Biochemical and Biophysical Research Communications 324 471-480.
95. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB et al. 2000 Loss of PTEN facilitates HIF-1-mediated gene expression. Genes and Development 14 391-396.